Stealth BioTherapeutics Corp. ADS
MITO
MITO was delisted on the 15th of November, 2022.
13 hedge funds and large institutions have $1.46M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
75% more capital invested
Capital invested by funds: $835K → $1.46M (+$625K)
30% more funds holding
Funds holding: 10 → 13 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$672K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
+$70.2K |
| 3 |
VF
Virtu Financial
New York
|
+$62.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$30.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$346K |
| 2 |
HF
HRT Financial
New York
|
-$23K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $849K | +$672K | +478,903 | +537% |
|
|
BBHC
2
Brown Brothers Harriman & Co
New York
| $262K | – | – | – |
|
|
3
Mercer Global Advisors
Denver,
Colorado
| $75K | +$70.2K | +50,000 | New |
|
|
VF
4
Virtu Financial
New York
| $67K | +$62.2K | +44,337 | New |
|
|
IC
5
Ikarian Capital
Dallas,
Texas
| $57K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $50K | +$30.1K | +21,446 | +176% |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $41K | +$38.3K | +27,282 | New |
|
|
TSS
8
Two Sigma Securities
New York
| $22K | +$20.8K | +14,851 | New |
|
9
Goldman Sachs
New York
| $22K | +$21K | +14,989 | New |
|
10
Morgan Stanley
New York
| $9K | – | – | – |
|
|
SFS
11
Sowell Financial Services
North Little Rock,
Arkansas
| $4K | +$4.12K | +2,939 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| $1K | -$9.98K | -7,115 | -91% |
|
13
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$323 | +230 | +38% |
|
|
PM
14
Prosight Management
Dallas,
Texas
| – | -$346K | -256,044 | Closed |
|
|
HF
15
HRT Financial
New York
| – | -$23K | -17,092 | Closed |
|
MITO Hedge Fund Activity: Q4 2020 in Review
13 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q4 2020, worth a combined $1.46M — up 75% from $835K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MITO positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $672K. The largest seller was Prosight Management, exiting entirely with an estimated $346K sold.
- 13 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q4 2020, up from 10 in Q3 2020.
- Funds reported $1.46M of Stealth BioTherapeutics Corp. ADS stock for Q4 2020, up 75% quarter-over-quarter.
- 6 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q4 2020 and 2 closed out, a net change of +4 holders.
- The largest Stealth BioTherapeutics Corp. ADS buyer in Q4 2020 was Renaissance Technologies, an estimated $672K added.
- The largest Stealth BioTherapeutics Corp. ADS seller in Q4 2020 was Prosight Management, an estimated $346K sold.
Based on aggregated 13F filings for Q4 2020.